PILA PHARMA AB
PILA | FN
Overview
Corporate Details
- ISIN(s):
- SE0015988274
- LEI:
- 6488Z7WG18Q0ZN0V0262
- Country:
- Sweden
- Address:
- Norra Vallgatan 72, 211 22 Malmö
- Website:
- N/A
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
PILA PHARMA AB develops treatments for metabolic disorders, including diabetes. Their research focuses on innovative drug therapies.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
Market Cap data is planned for a future update.
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Selvita S.A. | Poland | SLV | |
|
SHEARWATER GROUP PLC | United Kingdom | SWG | |
|
Shedir Pharma Group | Italy | SHE | |
|
Simris Group AB | Sweden | SIMRIS | |
|
SKILLCAST GROUP PLC | United Kingdom | SKL | |
|
Sopharma AD | Bulgaria | SFA | |
|
STADA Arzneimittel AG | Germany | SAZ | |
|
STENOCARE A/S | Denmark | STENO | |
|
Sunflower Sustainable Investments Ltd. | Israel | SNFL | |
/other/Swedencare_AB_publ-logo.png?Expires=1750108197&Signature=NZPkGqfuG5TL53gcmJQ1mvH~LMjtbSmyOiHxI12JnLBOP7-I0fnsv7V0ziKp5GXHDP2On5jBXMF5PPkFPSZSs7bTGBouscg8c-bPN0vP3Y66-G4b9Z1N0A7Q~nbrwuA~Q0zwmrP3aX3TP7IhVVdHEu-LE91HvHV8y1o6~fZ0JTb6IaZ48pZ6jXElZMMI180tJm391iGXDBtHR7AntG615sQ4iiQaQODtOZJ29w6D2ZsqqSDXK5siURKynceo7F80K5s6nTxVtvMoAVR~6HCx6Ozxk7xJVMhks5JqOpFhqZ4aYmbXvVzqqza45AaomH4Gb9XQEgImqJw2CY-5wGWldA__&Key-Pair-Id=K6QMJA61RGOXQ){kind=logo}
|
Swedencare AB (publ) | Sweden | SECARE |